Concepts (188)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Outpatients | 2 | 2022 | 253 | 1.380 |
Why?
|
| Intellectual Disability | 12 | 2024 | 1043 | 1.040 |
Why?
|
| Neurodevelopmental Disorders | 8 | 2024 | 458 | 1.030 |
Why?
|
| Genetic Testing | 6 | 2024 | 989 | 0.770 |
Why?
|
| Bacteriophage T4 | 1 | 2020 | 3 | 0.710 |
Why?
|
| Medicaid | 1 | 2022 | 238 | 0.700 |
Why?
|
| Mutation | 10 | 2022 | 5738 | 0.690 |
Why?
|
| Pedigree | 5 | 2023 | 1572 | 0.650 |
Why?
|
| Myopathies, Nemaline | 1 | 2018 | 8 | 0.640 |
Why?
|
| Tuberous Sclerosis | 1 | 2020 | 120 | 0.640 |
Why?
|
| Viral Proteins | 1 | 2020 | 338 | 0.610 |
Why?
|
| Troponin T | 1 | 2018 | 243 | 0.560 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2018 | 214 | 0.560 |
Why?
|
| Genes, BRCA2 | 1 | 2016 | 42 | 0.530 |
Why?
|
| Genes, BRCA1 | 1 | 2016 | 51 | 0.530 |
Why?
|
| Heterozygote | 3 | 2020 | 679 | 0.530 |
Why?
|
| DNA-Binding Proteins | 3 | 2021 | 2038 | 0.500 |
Why?
|
| Gene Deletion | 1 | 2018 | 799 | 0.500 |
Why?
|
| Haploinsufficiency | 3 | 2021 | 248 | 0.460 |
Why?
|
| Craniofacial Abnormalities | 3 | 2020 | 241 | 0.430 |
Why?
|
| Mutation, Missense | 6 | 2021 | 834 | 0.430 |
Why?
|
| Developmental Disabilities | 3 | 2023 | 683 | 0.400 |
Why?
|
| Genetic Association Studies | 4 | 2020 | 756 | 0.400 |
Why?
|
| Sequence Deletion | 4 | 2020 | 526 | 0.390 |
Why?
|
| Phenotype | 12 | 2023 | 4196 | 0.360 |
Why?
|
| Adenosine Triphosphatases | 2 | 2020 | 210 | 0.330 |
Why?
|
| Alleles | 5 | 2020 | 1587 | 0.320 |
Why?
|
| Histones | 3 | 2022 | 522 | 0.300 |
Why?
|
| Seizures | 2 | 2024 | 872 | 0.280 |
Why?
|
| Autism Spectrum Disorder | 2 | 2022 | 373 | 0.260 |
Why?
|
| Humans | 35 | 2024 | 121045 | 0.250 |
Why?
|
| Chaperonin Containing TCP-1 | 1 | 2024 | 9 | 0.240 |
Why?
|
| Abnormalities, Multiple | 3 | 2021 | 974 | 0.240 |
Why?
|
| Exons | 2 | 2018 | 793 | 0.240 |
Why?
|
| Protein Folding | 1 | 2024 | 214 | 0.220 |
Why?
|
| Counselors | 1 | 2023 | 22 | 0.220 |
Why?
|
| Texas | 2 | 2022 | 3508 | 0.220 |
Why?
|
| Goldenhar Syndrome | 1 | 2023 | 13 | 0.220 |
Why?
|
| Child | 13 | 2024 | 23950 | 0.210 |
Why?
|
| Cultural Competency | 1 | 2023 | 52 | 0.210 |
Why?
|
| Vulnerable Populations | 1 | 2024 | 141 | 0.200 |
Why?
|
| Laboratories | 1 | 2023 | 83 | 0.200 |
Why?
|
| Dwarfism | 2 | 2020 | 102 | 0.200 |
Why?
|
| Genetic Counseling | 1 | 2023 | 220 | 0.200 |
Why?
|
| Neoplasms | 1 | 2016 | 2729 | 0.190 |
Why?
|
| Thrombocytopenia | 1 | 2023 | 229 | 0.190 |
Why?
|
| Micrognathism | 1 | 2021 | 65 | 0.190 |
Why?
|
| Chromosome Disorders | 1 | 2023 | 311 | 0.190 |
Why?
|
| Hand Deformities, Congenital | 1 | 2021 | 89 | 0.180 |
Why?
|
| Calcineurin | 1 | 2021 | 100 | 0.180 |
Why?
|
| Hyperostosis, Cortical, Congenital | 1 | 2020 | 2 | 0.180 |
Why?
|
| Microcephaly | 3 | 2020 | 320 | 0.180 |
Why?
|
| Male | 18 | 2024 | 58908 | 0.180 |
Why?
|
| Hospitals | 1 | 2023 | 392 | 0.180 |
Why?
|
| Hypocalcemia | 1 | 2020 | 35 | 0.180 |
Why?
|
| Transcription Factors, General | 1 | 2020 | 8 | 0.180 |
Why?
|
| Exodeoxyribonucleases | 1 | 2020 | 47 | 0.180 |
Why?
|
| Loss of Function Mutation | 1 | 2021 | 139 | 0.170 |
Why?
|
| Hydrolysis | 1 | 2020 | 155 | 0.170 |
Why?
|
| Penetrance | 1 | 2020 | 100 | 0.170 |
Why?
|
| Neurofibromin 1 | 1 | 2019 | 42 | 0.170 |
Why?
|
| Leigh Disease | 1 | 2019 | 25 | 0.170 |
Why?
|
| Protein Binding | 2 | 2021 | 1733 | 0.160 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2020 | 3064 | 0.160 |
Why?
|
| Adenosine Triphosphate | 1 | 2020 | 288 | 0.160 |
Why?
|
| Neurofibromatosis 1 | 1 | 2019 | 58 | 0.160 |
Why?
|
| Skull | 1 | 2020 | 143 | 0.160 |
Why?
|
| Transcription Factors | 2 | 2020 | 2586 | 0.160 |
Why?
|
| Chromosomal Proteins, Non-Histone | 2 | 2021 | 214 | 0.160 |
Why?
|
| Retrospective Studies | 5 | 2023 | 15563 | 0.160 |
Why?
|
| Female | 15 | 2024 | 63993 | 0.160 |
Why?
|
| Genetic Diseases, Inborn | 2 | 2020 | 439 | 0.160 |
Why?
|
| Growth Disorders | 1 | 2020 | 209 | 0.160 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2021 | 380 | 0.160 |
Why?
|
| Aorta, Thoracic | 1 | 2023 | 489 | 0.160 |
Why?
|
| Adult | 9 | 2024 | 28363 | 0.160 |
Why?
|
| Cellular Senescence | 1 | 2019 | 156 | 0.150 |
Why?
|
| Cardiomyopathies | 1 | 2023 | 476 | 0.150 |
Why?
|
| Eye Abnormalities | 1 | 2018 | 108 | 0.150 |
Why?
|
| Glaucoma | 1 | 2018 | 88 | 0.150 |
Why?
|
| Mediator Complex | 1 | 2018 | 54 | 0.150 |
Why?
|
| CDC2 Protein Kinase | 1 | 2017 | 35 | 0.150 |
Why?
|
| Antigens, Nuclear | 1 | 2017 | 62 | 0.140 |
Why?
|
| Binding Sites | 1 | 2020 | 1291 | 0.140 |
Why?
|
| Motor Activity | 1 | 2020 | 507 | 0.140 |
Why?
|
| Homozygote | 1 | 2018 | 535 | 0.140 |
Why?
|
| Child, Preschool | 10 | 2024 | 13708 | 0.140 |
Why?
|
| Craniosynostoses | 1 | 2018 | 130 | 0.140 |
Why?
|
| Models, Molecular | 1 | 2020 | 1067 | 0.140 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2020 | 998 | 0.140 |
Why?
|
| Language Development Disorders | 1 | 2017 | 166 | 0.130 |
Why?
|
| Face | 1 | 2017 | 181 | 0.130 |
Why?
|
| Brain | 2 | 2024 | 2918 | 0.130 |
Why?
|
| Exome | 4 | 2024 | 1035 | 0.130 |
Why?
|
| DNA | 1 | 2020 | 1606 | 0.120 |
Why?
|
| Escherichia coli | 1 | 2020 | 973 | 0.120 |
Why?
|
| Facies | 3 | 2023 | 155 | 0.120 |
Why?
|
| Phosphoproteins | 1 | 2016 | 399 | 0.110 |
Why?
|
| Infant | 5 | 2020 | 12201 | 0.110 |
Why?
|
| Amino Acid Sequence | 1 | 2018 | 2668 | 0.110 |
Why?
|
| Epilepsy | 1 | 2021 | 847 | 0.110 |
Why?
|
| Amino Acid Substitution | 3 | 2020 | 384 | 0.110 |
Why?
|
| Aged | 3 | 2024 | 18399 | 0.110 |
Why?
|
| Sequence Analysis, DNA | 1 | 2019 | 1750 | 0.110 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2016 | 524 | 0.110 |
Why?
|
| Zebrafish | 3 | 2020 | 370 | 0.100 |
Why?
|
| Muscle, Skeletal | 1 | 2018 | 925 | 0.100 |
Why?
|
| Nerve Tissue Proteins | 1 | 2017 | 1107 | 0.090 |
Why?
|
| Adolescent | 7 | 2024 | 18730 | 0.090 |
Why?
|
| Syndrome | 3 | 2019 | 1116 | 0.090 |
Why?
|
| Disease Models, Animal | 1 | 2019 | 4255 | 0.080 |
Why?
|
| Middle Aged | 5 | 2024 | 25263 | 0.080 |
Why?
|
| Incidence | 1 | 2016 | 2965 | 0.080 |
Why?
|
| HEK293 Cells | 2 | 2021 | 738 | 0.080 |
Why?
|
| United States | 1 | 2022 | 10332 | 0.070 |
Why?
|
| Neurons | 3 | 2022 | 1914 | 0.060 |
Why?
|
| Gene Expression | 2 | 2021 | 1579 | 0.060 |
Why?
|
| Heart Defects, Congenital | 1 | 2017 | 1776 | 0.060 |
Why?
|
| Aged, 80 and over | 1 | 2016 | 6091 | 0.060 |
Why?
|
| Animals | 6 | 2023 | 33472 | 0.060 |
Why?
|
| Protein Subunits | 1 | 2024 | 164 | 0.060 |
Why?
|
| Medically Underserved Area | 1 | 2024 | 86 | 0.060 |
Why?
|
| Facial Asymmetry | 1 | 2023 | 18 | 0.050 |
Why?
|
| Chromosome Breakage | 1 | 2023 | 168 | 0.050 |
Why?
|
| Young Adult | 3 | 2024 | 8627 | 0.050 |
Why?
|
| Caenorhabditis elegans | 1 | 2024 | 221 | 0.050 |
Why?
|
| Proteome | 1 | 2024 | 233 | 0.050 |
Why?
|
| Dilatation | 1 | 2023 | 68 | 0.050 |
Why?
|
| Cohort Studies | 2 | 2024 | 4577 | 0.050 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2023 | 244 | 0.050 |
Why?
|
| Cell Proliferation | 2 | 2020 | 2297 | 0.050 |
Why?
|
| Frameshift Mutation | 1 | 2022 | 175 | 0.050 |
Why?
|
| Mitochondrial Proteins | 1 | 2023 | 240 | 0.050 |
Why?
|
| Protein Domains | 1 | 2022 | 228 | 0.050 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2024 | 3403 | 0.050 |
Why?
|
| Aryl Hydrocarbon Receptor Nuclear Translocator | 1 | 2021 | 4 | 0.050 |
Why?
|
| Autistic Disorder | 1 | 2024 | 343 | 0.050 |
Why?
|
| Hypoparathyroidism | 1 | 2020 | 11 | 0.050 |
Why?
|
| Forkhead Transcription Factors | 1 | 2023 | 369 | 0.050 |
Why?
|
| Chromosome Mapping | 1 | 2023 | 1068 | 0.040 |
Why?
|
| Mice | 3 | 2023 | 17432 | 0.040 |
Why?
|
| RNA-Binding Proteins | 1 | 2024 | 567 | 0.040 |
Why?
|
| Fibroblasts | 1 | 2024 | 877 | 0.040 |
Why?
|
| Muscle Hypotonia | 1 | 2021 | 186 | 0.040 |
Why?
|
| Osteochondrodysplasias | 1 | 2020 | 68 | 0.040 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2023 | 392 | 0.040 |
Why?
|
| Organogenesis | 1 | 2020 | 76 | 0.040 |
Why?
|
| Family | 1 | 2023 | 569 | 0.040 |
Why?
|
| Actins | 1 | 2021 | 340 | 0.040 |
Why?
|
| Electron Transport Complex IV | 1 | 2019 | 39 | 0.040 |
Why?
|
| Electron Transport | 1 | 2019 | 55 | 0.040 |
Why?
|
| Cell Nucleolus | 1 | 2019 | 56 | 0.040 |
Why?
|
| Organ Size | 1 | 2020 | 409 | 0.040 |
Why?
|
| Zebrafish Proteins | 1 | 2019 | 106 | 0.040 |
Why?
|
| Health Services Accessibility | 1 | 2024 | 569 | 0.040 |
Why?
|
| Aneuploidy | 1 | 2019 | 156 | 0.040 |
Why?
|
| Sequence Analysis, RNA | 1 | 2021 | 367 | 0.040 |
Why?
|
| Cyclin-Dependent Kinase 8 | 1 | 2018 | 12 | 0.040 |
Why?
|
| Transcriptome | 1 | 2024 | 900 | 0.040 |
Why?
|
| Transcription Initiation, Genetic | 1 | 2018 | 9 | 0.040 |
Why?
|
| Nuclear Family | 1 | 2018 | 50 | 0.040 |
Why?
|
| Drug Resistant Epilepsy | 1 | 2021 | 200 | 0.040 |
Why?
|
| Repressor Proteins | 1 | 2023 | 810 | 0.040 |
Why?
|
| United Kingdom | 1 | 2018 | 186 | 0.040 |
Why?
|
| Nerve Net | 1 | 2020 | 233 | 0.040 |
Why?
|
| Ubiquitination | 1 | 2018 | 172 | 0.040 |
Why?
|
| Axons | 1 | 2020 | 381 | 0.040 |
Why?
|
| Cerebral Cortex | 1 | 2020 | 441 | 0.040 |
Why?
|
| Larva | 1 | 2017 | 226 | 0.030 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2017 | 120 | 0.030 |
Why?
|
| Cell Movement | 1 | 2020 | 846 | 0.030 |
Why?
|
| Genomics | 1 | 2024 | 1473 | 0.030 |
Why?
|
| Chromatin | 1 | 2019 | 549 | 0.030 |
Why?
|
| Rats | 1 | 2022 | 3646 | 0.030 |
Why?
|
| Gene Editing | 1 | 2017 | 177 | 0.030 |
Why?
|
| Mothers | 1 | 2018 | 337 | 0.030 |
Why?
|
| Membrane Proteins | 1 | 2023 | 1524 | 0.030 |
Why?
|
| CRISPR-Cas Systems | 1 | 2017 | 246 | 0.030 |
Why?
|
| DNA Mutational Analysis | 1 | 2016 | 791 | 0.030 |
Why?
|
| Genotype | 1 | 2020 | 2534 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2020 | 2826 | 0.030 |
Why?
|
| Electroencephalography | 1 | 2018 | 839 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2022 | 2539 | 0.030 |
Why?
|
| DNA Methylation | 1 | 2019 | 979 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2020 | 1977 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2017 | 3068 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2019 | 3266 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2016 | 862 | 0.020 |
Why?
|